INHIBITORY EFFECTS OF QUASSINOIDS ON EPSTEIN-BARR-VIRUS ACTIVATION

被引:27
|
作者
OKANO, M
FUKAMIYA, N
TAGAHARA, K
TOKUDA, H
IWASHIMA, A
NISHINO, H
LEE, KH
机构
[1] KOBE PHARMACEUT UNIV,FAC PHARMACEUT SCI,KOBE 665,JAPAN
[2] KYOTO PREFECTURAL UNIV MED,DEPT BIOCHEM,KYOTO 602,JAPAN
[3] NATL INST CANC RES,DIV CANC PREVENT,TOKYO 103,JAPAN
[4] UNIV N CAROLINA,SCH MED,DIV MED CHEM & NAT PROD,NAT PROD LAB,CHAPEL HILL,NC 27599
关键词
ANTITUMOR PROMOTING EFFECT; EPSTEIN-BARR VIRUS ACTIVATION TEST; QUASSINOIDS; STRUCTURE-ACTIVITY RELATIONSHIPS;
D O I
10.1016/0304-3835(95)03839-O
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Short-term in vitro assays for tumor promoters and anti-tumor promoters (Epstein-Barr virus activation test) were carried out for 45 quassinoids. As a result, some quassinoids showed potent activity, more than 50% inhibition at a molar ratio of 1:1 (TPA/quassinoids). These results led to the following structure-activity relationships: (1) a methyleneoxy bridge and side chain enhance the activity and (2) a sugar moiety reduces the activity.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 50 条
  • [21] EPSTEIN-BARR-VIRUS AND DEPRESSION
    FUDENBERG, HH
    ALLEN, AD
    PITTS, FN
    ALLEN, RE
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1987, 144 (10): : 1374 - 1374
  • [22] EPSTEIN-BARR-VIRUS IN CHILDREN
    SEIGNEURIN, JM
    [J]. ANNALES DE PEDIATRIE, 1987, 34 (07): : 541 - 546
  • [23] Inhibitory effects of lapachol derivatives on Epstein-Barr virus activation
    Sacau, EP
    Estévez-Braun, A
    Ravelo, AG
    Ferro, EA
    Tokuda, H
    Mukainaka, T
    Nishino, H
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (04) : 483 - 488
  • [24] EPSTEIN-BARR-VIRUS ENCEPHALITIS
    SANYAL, D
    KUDESIA, G
    YOUNG, M
    [J]. JOURNAL OF INFECTION, 1991, 22 (01) : 101 - 102
  • [25] EPSTEIN-BARR-VIRUS AND LYMPHOMA
    RICKINSON, AB
    [J]. BRITISH JOURNAL OF CANCER, 1987, 55 (03) : 333 - 333
  • [26] Inhibitory effects of anthraquinones and bianthraquinones on Epstein-Barr virus activation
    Koyama, J
    Morita, I
    Tagahara, K
    Ogata, M
    Mukainaka, T
    Tokuda, H
    Nishino, H
    [J]. CANCER LETTERS, 2001, 170 (01) : 15 - 18
  • [27] EPSTEIN-BARR-VIRUS AND DEPRESSION
    DELISI, LE
    NURNBERGER, JI
    GOLDIN, LR
    SIMMONSALLING, S
    GERSHON, ES
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1986, 43 (08) : 815 - 816
  • [28] INHIBITORY EFFECTS OF DIHYDROAGAROFURAN SESQUITERPENES ON EPSTEIN-BARR-VIRUS ACTIVATION (CANCER LETTERS, VOL 65, PG 19, 1992)
    TAKAISHI, Y
    UJITA, K
    TOKUDA, H
    NISHINO, H
    IWASHIMA, A
    FUJITA, T
    [J]. CANCER LETTERS, 1992, 67 (2-3) : 215 - 215
  • [29] MECHANISMS OF TRANSCRIPTIONAL ACTIVATION BY ZEBRA, AN EPSTEIN-BARR-VIRUS PROTEIN
    CHI, T
    LIEBERMAN, P
    LEHMAN, A
    CAREY, M
    [J]. FASEB JOURNAL, 1995, 9 (06): : A1462 - A1462
  • [30] EPSTEIN-BARR-VIRUS INFECTED T-LYMPHOCYTES IN EPSTEIN-BARR-VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME
    KAWAGUCHI, H
    MIYASHITA, T
    HERBST, H
    NIEDOBITEK, G
    ASADA, M
    TSUCHIDA, M
    HANADA, R
    KINOSHITA, A
    SAKURAI, M
    KOBAYASHI, N
    MIZUTANI, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03): : 1444 - 1450